Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Single-Center, Double-Blind, Placebo-Controlled, Single-Dose, 4-Period Crossover, Drug-Alcohol Interaction Study in Lemborexant in Healthy Subjects

Next Previous
Trial Profile

Single-Center, Double-Blind, Placebo-Controlled, Single-Dose, 4-Period Crossover, Drug-Alcohol Interaction Study in Lemborexant in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lemborexant (Primary) ; Alcohol
  • Indications Circadian rhythm sleep disorders; Insomnia; Sleep apnoea syndrome
  • Focus Pharmacodynamics
  • Sponsors Eisai Inc

    • Most Recent Events

    • 16 Oct 2018 Status changed from recruiting to completed.
    • 19 Jul 2018 Planned End Date changed from 18 Jun 2018 to 12 Sep 2018.
    • 19 Jul 2018 Planned primary completion date changed from 18 Jun 2018 to 12 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top